News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > Other mandatory announcements > Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

29. July 2024 - 13:18 (CEST)

Preliminary announcement | 29 July 2024 15:39

Epigenomics AG / Preliminary announcement on the disclosure of financial statements
Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 29.07.2024 / 15:39 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Epigenomics AG hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report (half-year/Q2)

Language: German
Date of disclosure: July 30, 2024
Address: https://www.epigenomics.com/de/news-investoren/finanzberichte/

29.07.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Epigenomics AG
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany
Internet: www.epigenomics.com
End of News EQS News Service

Archive

News Categories

Media Contact

Frederic Hilke (IR.on AG) T +49 221 9140-9719 ir@epigenomics.com